Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Allergic Rhinitis: later-stage trial registry
2 of 24 indexed Allergic Rhinitis trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #686 of 28,707 conditions by registered trial count.
24 US clinical trials · 2 currently recruiting · #686 of 28,707 conditions by registered trial count
Allergic Rhinitis: 24 US clinical trials tracked, 2 recruiting.
Allergic Rhinitis is the subject of 24 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 13 are in Phase 3-4 (later-stage) and 6 in Phase 1-2 (earlier-stage). The most active sponsor is Sanofi, running 2 of these trials.
Enrollment posture brief
Registry condition allergic-rhinitis
OPEN 2 | RECR 8% | LATE 13 | EARLY 6 | RANK #686 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Anorexia (8% recruiting · 12 trials)
Allergic Rhinitis lists 2 open slots (8% of 24 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Allergic Rhinitis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Allergic Rhinitis is recruiting below its size-band peers.
2 of 24 indexed trials (8.3%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Allergic Rhinitis trials is spread across many organizations.
Sanofi accounts for 2 of 24 trials (8.3%). 21 distinct sponsors appear on at least one study for this condition label.
-
Most Allergic Rhinitis trials plan to enrol fewer than 100 people.
Median target enrolment is 59 among the 24 trials that report a genuine target (sentinel values excluded). 18 of those (75%) plan for fewer than 100 participants.
-
Allergic Rhinitis research is mostly interventional.
22 interventional and 2 observational studies make up this index (91.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
24 total, page 1 of 1
Does Batten Grafting Improve Nasal Outcomes in Septoplasty and Turbinate Reduction?
Northwell Health
NCT05287841
Viral Mucosal Reprogramming
The University of Texas Medical Branch, Galveston
NCT05331170
Repurposed Use of Allergic Rhinitis and Allergic Asthma Drug to Reduce Vertigo and Hearing Loss in Meniere's Disease
House Ear Institute
NCT04815187
Efficacy Study of Sublingual Immunotherapy to Treat Ragweed Allergies
Greer Laboratories
NCT00599872
3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis
Meda Pharmaceuticals
NCT01794741
Study to Assess the Efficacy of Anti-Bet v 1 Monoclonal Antibodies in Adults to Reduce Symptoms of Seasonal Allergic Rhinitis
Regeneron Pharmaceuticals
NCT04709575
Fexofenadine (Allegra®) in Healthy Adults Who Have Been Identified as Slow Metabolizers for Desloratadine
Sanofi
NCT00636870
Dupilumab As An Adjunct For Subcutaneous Grass Immunotherapy
Regeneron Pharmaceuticals
NCT03558997
Evaluation of the Sensory Attributes of Olopatadine 0.6% and Azelastine 137mcg Nasal Sprays in Patients w/Allergic Rhinitis
Alcon Research
NCT00772304
Comparability and Standardization of Controlled Allergen Challenge Facilities
Queen's University
NCT02543346
Validation of Laser Doppler Flowmetry to Identify Allergic Rhinitis Patients With Pharmacogenetic Alterations in Histamine Metabolism
Children's Mercy Hospital Kansas City
NCT00362999
A Study Evaluating Effects of Intranasal JNJ-17166864 on Symptoms of Allergic Rhinitis in Adults
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
NCT00604123
Association of Transcutaneous Pulse CO-oximetry With Inflammatory Lung Diseases
Boston Children's Hospital
NCT02831348
Effects of Diesel Exhaust Followed by Administration of Nasal Spray Flu Vaccine on Individuals With & Without Allergies
University of North Carolina, Chapel Hill
NCT00617110
Fexofenadine HCl 180 mg, Desloratadine 5 mg and Placebo in Suppression of Wheal and Flare Induced by Histamine
Sanofi
NCT00637585
The Effect of Cetirizine on Bronchoconstriction
New York City Health and Hospitals Corporation
NCT03340740
Comparison Between Systemic Exposure to Ciclesonide Nasal Spray, Ciclesonide HFA Nasal Aerosol and Orally Inhaled Ciclesonide (BY9010/M1-422)
Covis Pharma S.à.r.l.
NCT00458835
Sunovion Growth Study Pediatric Subjects With Mild Asthma & Allergic Rhinitis
West Penn Allegheny Health System
NCT01550471
A Safety and Immunogenicity Phase IC Study of CryJ2 -DNA-LAMP Plasmid Vaccine for Assessment of Intradermal (ID) Route of Administration Using the Biojector 2000 Device
Immunomic Therapeutics
NCT02146781
Factors Involved in Dymista's Superior Clinical Efficacy in the Treatment of Seasonal Allergic Rhinitis
University of Chicago
NCT02402465
Topical ASP-1001 (Contrast Media Formulation) and the Acute Response to Nasal Allergen Challenge (NAC)
University of Chicago
NCT00791102
The Effect of Omalizumab on Responses to Cat Allergen Challenge
Johns Hopkins University
NCT00604786
Effects of AkPharma's Calcium Glycerophosphate Nasal Spray Wash
Drexel University
NCT01647633
Immunologic Basis of Anti-IgE Therapy (Study II: On Patients With Asthma)
University of California, Davis
NCT00367016
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 4 |
| Phase 3 | 3 |
| Phase 4 | 10 |
Top Sponsors
Named interventions
Most-linked intervention names on Allergic Rhinitis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Allergic Rhinitis trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Allergic Rhinitis page
24 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Allergic Rhinitis trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Sanofi sponsors the most Allergic Rhinitis trials on record, review their full trial history before evaluating a specific study. See Sanofi's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Allergic Rhinitis condition card totals 24 registered trials; most-linked intervention Placebo; top US site state Missouri. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.